Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Niagen Bioscience (NAGE) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Niagen Bioscience's Treasury Shares rose 12207.6% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 12207.6%. This contributed to the annual value of $609000.0 for FY2024, which is 339.56% up from last year.
  • Latest data reveals that Niagen Bioscience reported Treasury Shares of $1.5 million as of Q3 2025, which was up 12207.6% from $1.5 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Treasury Shares high stood at $1.5 million for Q1 2025, and its period low was $589000.0 during Q4 2023.
  • In the last 4 years, Niagen Bioscience's Treasury Shares had a median value of $774000.0 in 2023 and averaged $928909.1.
  • As far as peak fluctuations go, Niagen Bioscience's Treasury Shares crashed by 938.46% in 2023, and later surged by 12207.6% in 2025.
  • Niagen Bioscience's Treasury Shares (Quarter) stood at $650000.0 in 2022, then decreased by 9.38% to $589000.0 in 2023, then grew by 3.4% to $609000.0 in 2024, then surged by 149.43% to $1.5 million in 2025.
  • Its Treasury Shares was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.